Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Mofenson LM"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 61
Tytuł:
U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States [corrected] [published erratum appears in MMWR MORB MORTAL WKLY REP 2002 Nov 29;51(47):1075].
Autorzy:
Mofenson LM (AUTHOR)
US Department of Health and Human Services. Centers for Disease Control and Prevention (CORPORATE AUTHOR)
Pokaż więcej
Źródło:
MMWR: Morbidity & Mortality Weekly Report. 11/22/2002 Supplement SS-8, Vol. 51 Issue 46, p1-1. 38p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
Autorzy:
Mofenson LM (AUTHOR)
Brady MT (AUTHOR)
Danner SP (AUTHOR)
Dominguez KL (AUTHOR)
Hazra R (AUTHOR)
Handelsman E (AUTHOR)
Havens P (AUTHOR)
Nesheim S (AUTHOR)
Read JS (AUTHOR)
Serchuck L (AUTHOR)
Van Dyke R (AUTHOR)
Centers for Disease Control and Prevention (CORPORATE AUTHOR)
Pokaż więcej
Źródło:
MMWR Recommendations & Reports. 9/4/2009, Vol. 58 Issue RR-11, p1-166. 166p.
URL:
44482281  Link otwiera się w nowym oknie
Periodyk
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Interaction between timing of perinatal human immunodeficiency virus infection and the design of preventive and therapeutic interventions.
Autorzy:
Mofenson, LM
Pokaż więcej
Źródło:
Acta Paediatrica; Jun1997, Vol. 86 Issue S421, p1-9, 9p
Czasopismo naukowe
Szczegóły
Tytuł:
Reducing the risk of perinatal HIV-1 transmission with zidovudine: results and implications of AIDS Clinical Trials Group protocol 076.
Autorzy:
Mofenson, LM
Pokaż więcej
Źródło:
Acta Paediatrica; Jun1997, Vol. 86 Issue S421, p89-96, 8p
Czasopismo naukowe
Szczegóły
Tytuł:
Surveillance of ARV safety in pregnancy and breastfeeding: towards a new framework.
Autorzy:
Renaud F; Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, World Health Organization, Geneva, Switzerland.
Mofenson LM; Research Department, Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC, USA.
Bakker C; Seconded National Expert Translational Sciences Office Scientific Evidence Generation Department, European Medicines Agency, Amsterdam, The Netherlands.
Dolk H; EUROmediCAT, Institute for Nursing and Health Research, Ulster University, Jordanstown, United Kingdom.
Leroy V; Centre d'Epidémiologie et Recherche en Santé des POPulations (CERPOP), Inserm, Université de Toulouse Paul Sabatier, Toulouse, France.
Namiba A; 4M Network of Mentor Mothers, London, UK.
Sahin L; Division of Pediatrics and Maternal Health, US Food and Drug Administration, Silver Spring, Maryland, USA.
Shapiro R; Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Slogrove A; Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Worcester, South Africa.
Thorne C; Great Ormond Street Institute of Child Health, University College London, London, UK.
Vicari M; HIV Programmes and Advocacy Department, International AIDS Society, Geneva, Switzerland.
Low-Beer D; Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, World Health Organization, Geneva, Switzerland.
Doherty M; Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, World Health Organization, Geneva, Switzerland.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2022 Jul; Vol. 25 Suppl 2, pp. e25922.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Feeding*
Anti-Retroviral Agents/*adverse effects
Adolescent ; Anti-Retroviral Agents/therapeutic use ; Child ; Cohort Studies ; Europe ; Female ; HIV Infections/drug therapy ; HIV Infections/epidemiology ; HIV Infections/prevention & control ; Humans ; Infant ; North America ; Pregnancy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical and population-based study design considerations to accelerate the investigation of new antiretrovirals during pregnancy.
Autorzy:
Brummel SS; Department of Biostatistics, Center for Biostatistics in AIDS Research, Boston, Massachusetts, USA.; Harvard T.H. Chan School of Public Heath, Boston, Massachusetts, USA.
Stringer J; School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
Mills E; MTEK Sciences, Vancouver, British Columbia, Canada.; MTEK Sciences, Kigali, Rwanda.
Tierney C; Department of Biostatistics, Center for Biostatistics in AIDS Research, Boston, Massachusetts, USA.; Harvard T.H. Chan School of Public Heath, Boston, Massachusetts, USA.
Caniglia EC; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Colbers A; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Chi BH; Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Best BM; Skaggs School of Pharmacy and Pharmaceutical Sciences, San Diego, California, USA.; Pediatrics Department - Rady Children's Hospital San Diego, University of California San Diego, La Jolla, California, USA.
Gaaloul ME; Product Development, Medicines for Malaria Venture, Geneva, Switzerland.
Hillier S; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh and the Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA.
Jourdain G; MIVEGEC University Montpellier, Montpellier, France.
Khoo SH; Department of Pharmacology, University of Liverpool, Liverpool, UK.
Mofenson LM; Research Department, Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC, USA.
Myer L; Division of Epidemiology & Biostatistics, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa.
Nachman S; Department of Pediatrics, The State University of New York (SUNY), Stony Brook, New York, USA.
Stranix-Chibanda L; Child and Adolescent Health Unit, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
Clayden P; HIV i-Base, London, UK.
Sachikonye M; HIV i-Base, London, UK.
Lockman S; Harvard T.H. Chan School of Public Heath, Boston, Massachusetts, USA.; Brigham and Women's Hospital, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2022 Jul; Vol. 25 Suppl 2, pp. e25917.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Anti-Retroviral Agents*/adverse effects
Anti-Retroviral Agents*/therapeutic use
HIV Infections*/drug therapy
Pregnancy Complications, Infectious*/drug therapy
Female ; Humans ; Pregnancy ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pregnancy and medicines: time for paradigm change.
Autorzy:
Saint-Raymond A; Paris, France.
Mofenson LM; Research Department, Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC, USA.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2022 Jul; Vol. 25 Suppl 2, pp. e25906.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*
Female ; Humans ; Pregnancy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A randomized controlled trial evaluating the effects of a family-centered HIV care model on viral suppression and retention in care of HIV-positive children in Eswatini.
Autorzy:
Ashburn K; Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), Washington, DC, United States of America.
Chouraya C; Elizabeth Glaser Pediatric AIDS Foundation, Mbabane, Eswatini.
Khumalo P; Elizabeth Glaser Pediatric AIDS Foundation, Mbabane, Eswatini.
Mpango L; Elizabeth Glaser Pediatric AIDS Foundation, Mbabane, Eswatini.
Mthethwa N; Eswatini Ministry of Health, Mbabane, Eswatini.
Machekano R; Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), Washington, DC, United States of America.
Guay L; Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), Washington, DC, United States of America.; Department of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, DC, United States of America.
Mofenson LM; Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), Washington, DC, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Aug 24; Vol. 16 (8), pp. e0256256. Date of Electronic Publication: 2021 Aug 24 (Print Publication: 2021).
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Family Nursing*
Anti-HIV Agents/*administration & dosage
HIV/*drug effects
HIV Infections/*drug therapy
Adolescent ; CD4 Lymphocyte Count ; Caregivers ; Child ; Child, Preschool ; Eswatini/epidemiology ; Family ; Female ; HIV/pathogenicity ; HIV Infections/virology ; Humans ; Infant ; Infant, Newborn ; Male ; Pediatrics ; Retention in Care ; Standard of Care ; Viral Load/drug effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial.
Autorzy:
Stranix-Chibanda L; Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.
Tierney C; Department of Biostatistics, Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, MA, United States of America.
Sebikari D; Johns Hopkins University Research Collaboration, Makerere University, Kampala, Uganda.
Aizire J; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MA, United States of America.
Dadabhai S; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MA, United States of America.
Zanga A; Radiology Department, University of Zimbabwe Faculty of Medicine and Health Sciences, Harare, Zimbabwe.
Mukwasi-Kahari C; Radiology Department, University of Zimbabwe Faculty of Medicine and Health Sciences, Harare, Zimbabwe.
Vhembo T; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.
Violari A; Perinatal HIV Research Unit, Johannesburg, South Africa.
Theron G; Stellenbosch University, Cape Town, South Africa.
Moodley D; Centre Aids Prevention Research South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
George K; FHI 360, IMPAACT Operations Center, Durham, NC, United States of America.
Fan B; Radiology and Biomedical Imaging Unit, University of California San Francisco, San Francisco, CA, United States of America.
Sommer MJ; Radiology and Biomedical Imaging Unit, University of California San Francisco, San Francisco, CA, United States of America.
Browning R; Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MA, United States of America.
Mofenson LM; Research Department, Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC, United States of America.
Shepherd J; Radiology and Biomedical Imaging Unit, University of California San Francisco, San Francisco, CA, United States of America.; University of Hawaii Cancer Center, Honolulu, Hawaii.
Nelson B; Department of Biostatistics, Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, MA, United States of America.
Fowler MG; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MA, United States of America.
Siberry GK; United States Agency for International Development, Arlington, VA, United States of America.
Pokaż więcej
Corporate Authors:
PROMISE P1084s study team
Źródło:
PloS one [PLoS One] 2021 Feb 05; Vol. 16 (2), pp. e0246272. Date of Electronic Publication: 2021 Feb 05 (Print Publication: 2021).
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms:
Breast Feeding*
Anti-HIV Agents/*therapeutic use
Bone Density/*drug effects
HIV Infections/*drug therapy
Postpartum Period/*drug effects
Tenofovir/*therapeutic use
Absorptiometry, Photon ; Adult ; Anti-HIV Agents/administration & dosage ; Anti-HIV Agents/adverse effects ; Drug Therapy, Combination ; Emtricitabine/administration & dosage ; Emtricitabine/therapeutic use ; Female ; Humans ; Lopinavir/administration & dosage ; Lopinavir/therapeutic use ; Ritonavir/administration & dosage ; Ritonavir/therapeutic use ; Tenofovir/administration & dosage ; Tenofovir/adverse effects ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
'There are no more secrets': acceptability of a family-centered model of care for HIV positive children in Eswatini.
Autorzy:
Khumalo PN; Elizabeth Glaser Pediatric AIDS Foundation, Mbabane, Eswatini. .
Katirayi L; Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), Washington, DC, USA.
Ashburn K; Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), Washington, DC, USA.
Chouraya C; Elizabeth Glaser Pediatric AIDS Foundation, Mbabane, Eswatini.
Mpango L; Elizabeth Glaser Pediatric AIDS Foundation, Mbabane, Eswatini.
Mthethwa N; Eswatini Ministry of Health, Mbabane, Eswatini.
Mofenson LM; Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), Washington, DC, USA.
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2020 Oct 15; Vol. 20 (1), pp. 951. Date of Electronic Publication: 2020 Oct 15.
Typ publikacji:
Journal Article
MeSH Terms:
Disclosure*
Family/*psychology
HIV Infections/*therapy
Patient Acceptance of Health Care/*statistics & numerical data
Adolescent ; Adult ; Caregivers/psychology ; Caregivers/statistics & numerical data ; Child ; Child, Preschool ; Eswatini ; Female ; Health Personnel/psychology ; Health Personnel/statistics & numerical data ; Humans ; Infant ; Infant, Newborn ; Male ; Middle Aged ; Models, Organizational ; Pilot Projects ; Qualitative Research ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Accelerating progress towards the elimination of mother-to-child transmission of HIV: a narrative review.
Autorzy:
Chi BH; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Mbori-Ngacha D; United Nations Children's Fund (UNICEF), New York, NY, USA.
Essajee S; United Nations Children's Fund (UNICEF), New York, NY, USA.
Mofenson LM; Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC, USA.
Tsiouris F; ICAP at Columbia University, New York, NY, USA.
Mahy M; Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland.
Luo C; United Nations Children's Fund (UNICEF), New York, NY, USA.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2020 Aug; Vol. 23 (8), pp. e25571.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Pregnancy Complications, Infectious*
Anti-HIV Agents/*therapeutic use
HIV Infections/*prevention & control
Infectious Disease Transmission, Vertical/*prevention & control
Adult ; Breast Feeding ; Child ; Delivery of Health Care ; Evidence-Based Practice ; Female ; HIV Infections/transmission ; Humans ; Infant, Newborn ; Pregnancy ; Prenatal Care ; Social Support
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading?
Autorzy:
Joseph Davey DL; Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, CA, USA.; Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Pintye J; Department of Global Health, University of Washington, Seattle, WA, USA.
Baeten JM; Department of Global Health, University of Washington, Seattle, WA, USA.; Department of Epidemiology, University of Washington, Seattle, WA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA.
Aldrovandi G; Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Baggaley R; World Health Organization, Geneva, Switzerland.
Bekker LG; Faculty of Health Sciences, Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, NC, South Africa.
Celum C; Department of Global Health, University of Washington, Seattle, WA, USA.
Chi BH; Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Coates TJ; Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Haberer JE; Center for Global Health, Massachusetts General Hospital, Boston, MA, USA.
Heffron R; Department of Global Health, University of Washington, Seattle, WA, USA.; Department of Epidemiology, University of Washington, Seattle, WA, USA.
Kinuthia J; Department of Global Health, University of Washington, Seattle, WA, USA.; Department of Research and Programs, Kenyatta National Hospital, Nairobi, Kenya.
Matthews LT; Department of Medicine, University of Alabama, Birmingham, AL, USA.
McIntyre J; Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.; ANOVA, Johannesburg, South Africa.
Moodley D; Department of Obstetrics and Gynaecology, University of KwaZulu-Natal, Durban, South Africa.; Centre for AIDS Research in South Africa, Durban, South Africa.
Mofenson LM; Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC, USA.
Mugo N; Department of Global Health, University of Washington, Seattle, WA, USA.; Center for Clinical Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Myer L; Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Mujugira A; Department of Global Health, University of Washington, Seattle, WA, USA.; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
Shoptaw S; Geffen School of Medicine, University of California, Los Angeles, CA, USA.; Department of Family Medicine, University of California, Los Angeles, CA, USA.
Stranix-Chibanda L; University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.
John-Stewart G; Department of Global Health, University of Washington, Seattle, WA, USA.; Department of Epidemiology, University of Washington, Seattle, WA, USA.
Pokaż więcej
Corporate Authors:
PrEP in Pregnancy Working Group
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2020 Jan; Vol. 23 (1), pp. e25426.
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Systematic Review
MeSH Terms:
Anti-HIV Agents/*therapeutic use
HIV Infections/*drug therapy
Pregnancy Complications, Infectious/*drug therapy
Adult ; Anti-HIV Agents/adverse effects ; Breast Feeding ; Female ; HIV Infections/physiopathology ; HIV Infections/virology ; HIV-1/drug effects ; HIV-1/physiology ; Humans ; Postnatal Care ; Pre-Exposure Prophylaxis/methods ; Pregnancy ; Pregnancy Complications, Infectious/physiopathology ; Pregnancy Complications, Infectious/virology ; Tenofovir/adverse effects ; Tenofovir/therapeutic use ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects.
Autorzy:
Mofenson LM; Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC, USA.
Pozniak AL; Chelsea and Westminster Hospital NHS Foundation Trust, London School of Hygiene and Tropical Medicine, London, UK.
Wambui J; National Empowerment Network of people living with HIV/AIDS in Kenya (NEPHAK), Nairobi, Kenya.
Raizes E; Centers for Disease Control and Prevention, Atlanta, GA, USA.
Ciaranello A; Massachusetts General Hospital, Boston, MA, USA.
Clayden P; HIV i-Base, London, UK.
Ehrenkranz P; Bill & Melinda Gates Foundation, Seattle, WA, USA.
Fakoya A; Global Fund, Geneva, Switzerland.
Hill A; University of Liverpool, Liverpool, UK.
Khoo S; University of Liverpool, Liverpool, UK.
Mahaka I; Pangaea Zimbabwe AIDS Trust, Harare, Zimbabwe.
Modi S; Centers for Disease Control and Prevention, Atlanta, GA, USA.
Moore C; Centers for Disease Control and Prevention, Atlanta, GA, USA.
Phillips A; University College London, London, UK.
Siberry G; US Agency for International Development, Arlington, VA, USA.
Sikwese K; African Community Advisory Board (AFROCAB), Luska, Zambia.
Thorne C; University College London Institute of Child Health, London, UK.
Watts HD; Office of the US Global AIDS Coordinator, Washington, DC, USA.
Doherty M; World Health Organization, Geneva, Switzerland.
Ford NP; World Health Organization, Geneva, Switzerland.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2019 Jul; Vol. 22 (7), pp. e25352.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections/*drug therapy
Heterocyclic Compounds, 3-Ring/*adverse effects
Heterocyclic Compounds, 3-Ring/*therapeutic use
Neural Tube Defects/*chemically induced
Adolescent ; Anti-HIV Agents/adverse effects ; Anti-HIV Agents/therapeutic use ; Botswana/epidemiology ; Female ; HIV Infections/epidemiology ; HIV-1 ; Humans ; Oxazines ; Piperazines ; Pregnancy ; Pregnancy Complications/chemically induced ; Pyridones ; Risk Assessment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 61

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies